Abstract
Rare diseases, including those of genetic origin, are defined by the European Union as life-threatening or chronically debilitating diseases which are of such low prevalence (less than 5 per 10,000). The specificities of rare diseases – limited number of patients and scarcity of relevant knowledge and expertise – single them out as a unique domain of very high European added-value. The legal instruments at the disposal of the European Union, in terms of the Article 152 of the Treaties of the European Union, are very limited. However a combination of instruments using the research and the pharmaceutical legal basis and an intensive and creative use of funding from the First Public Health Programme 2003–2008 and from the Second Health Programme 2008–2013 has permitted to create a solid basis that Member States have considered enough to put rare diseases in a privileged position in the health agenda. The adoption of the Commission Communication, in November 2008, and of the Council Recommendation, in June 2009, and the future adoption of the Directive on Cross-border healthcare, maybe during 2010, have created an operational framework to act in the field of rare disease with European coordination in several areas (classification and codification, European Reference Networks, orphan drugs, European Committee of Experts, etc.). In conclusion, Rare diseases is an area with enormous and practical potentialities for the European cooperation.
References
BBMRI. Biobanking and Biomolecular Resources Research Infrastucture. http://www.bbmri.eu/
Commission of the European Communities (1999) Decision No 1295/1999/EC of the European Parliament and of the Council of 29 April 1999 adopting a programme of Community action on rare diseases within the framework for action in the field of public health (1999 to 2003). http://eur-lex.europa.eu/pri/en/oj/dat/1999/l_155/l_15519990622en00010005.pdf
Commission of the European Communities (2000) Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexapi!prod!CELEXnumdoc&lg = en&numdoc = 32000R0141&model = guichett)
Commission of the European Communities (2007) Web site of the European Commission on the Seventh Framework Programme (2007–2013). http://ec.europa.eu/research/fp7/
Commission of the European Communities (2008) Communication COM (2008) 679 final from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Rare Diseases: Europe’s challenges. http://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf
Commission of the European Communities (2008) Proposal for a Directive of the European Parliament and of the Council on the application of patients’ rights in cross-border healthcare. http://ec.europa.eu/health/ph_overview/co_operation/healthcare/cross-border_healthcare_en.htm
Commission of the European Communities (2009) Council Recommendation of 8 June 2009 on an action in the field of rare diseases. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri = OJ:C:2009:151:0007:0010:EN:PDF
Commission Decision of 30 November 2009 establishing a European Union Committee of Experts on Rare Diseases (2009/872/EC) http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri = OJ:L:2009:315:0018:0021:EN:PDF
Commission of the European Communities (2010) European Network of References for Rera Diseases. http://ec.europa.eu/health/ph_threats/non_com/rare_8_en.htm
European Medicines Agency (2009) Annual report of the European Medicines Agency 2008. Adopted by the Management Board on 7 May 2009. http://www.emea.europa.eu/pdfs/general/direct/emeaar/AnnualReport2008.pdf
EUROPLAN. The European Project for Rare Diseases National Plans Development (2010) A three-year project supported by the European Union. http://www.europlanproject.eu/
ENERCA European Network for Rare and Congenital Anomalies (2010) A project supported by the European Union http://www.enerca.org/
E-RARE (2010) ERA-Net for research programs on rare diseases. http://www.e-rare.eu/
EUROBIOBANK (2010) European Network of DNA, cell and tissue bank for rare diseases http://www.eurobiobank.org
EUROCAT (2005) Prevention of neural tube defects by periconceptional folic acid supplementation in Europe. http://www.eurocat-network.eu/content/Special-Report-NTD-2ndEd-PartI.pdf
EUROCAT (European Surveillance on Congenital Anomalies) (2010) A project supported by the European Union. http://www.eurocat.ulster.ac.uk/index.html
EUROGENTEST. Harmonizing genetic testing across Europe http://www.eurogentest.org/
EURORDIS (European Organisation for Rare Diseases) (2010) http://www.eurordis.org
EURORDIS (European Organisation for Rare Diseases) (2010) The voice of 12 000 patients. http://www.eurordis.org/IMG/pdf/voice_12000_patients/EURORDISCARE_FULLBOOKr.pdf
EuroWilson (2010) European Clinical Database for Wilson’s disease. A project supported by the European Union. http://www.eurowilson.org/en/home/index.phtml
Ministry of Health of Bulgaria (2009) Bulgarian National Plan for Rare Diseases 2009–2013 (Genetic, congenital malformation and nonhereditary diseases). http://www.raredis.org/pub/events/NPRD.pdf
Ministry of Health of Greece (2008) Greek National Plan on Rare Diseases 2008–2012 http://www.ygeianet.gov.gr/HealthMapUploads/Files/SPANIES_PATHISEIS_TELIKO_LOW.pdf
Ministry of Health of Portugal (2008) Portuguese National Plan on Rare Diseases 2008–2015 http://ec.europa.eu/health/ph_threats/non_com/docs/portugal.pdf
Ministry of Health and Social Affaires of Spain (2009) Rare Diseases Strategy of the Spanish National Health System http://www.msc.es/organizacion/sns/planCalidadSNS/docs/enfermedadesRaras.pdf
Ministry of Health and Social Protection of France (2004) French National Plan for Rare Diseases 2005–2008 “Ensuring equity in the access to diagnosis, treatment and provision of care”. http://www.orpha.net/actor/EuropaNews/2006/doc/French_National_Plan.pdf
Orphanet (2010) The Portal on Rare Diseases and Orphan Drugs. http://www.orpha.net/
Orphanet (2010) Prevalence of rare diseases: A bibliographic survey November 2009 http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf
Orphanet Report Series (2009) Patient registries in Europe http://www.orpha.net/orphacom/cahiers/docs/GB/Registries.pdf
Report of the Workshop on Patient’s Registries for Rare Disorders – EPPOSI – June 2009 http://www.epposi.org/upl/1/en/doc/Registries%202009%20final.pdf
Rare Bleeding Disorders Database (2010) A project supported by the European Union, http://www.rbdd.org/
Rare Diseases Task Force (2006) Centres of Reference for rare diseases in Europe: State-of-the-art in 2006 and recommendations of the Rare Diseases Task Force. A technical and scientific report from an expert group of the European Union Rare Diseases Task Force. http://ec.europa.eu/health/ph_threats/non_com/docs/contribution_policy.pdf
World Health Organisation (WHO) International Classification of Diseases. http://www.who.int/classifications/icd/en/index.html
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Netherlands
About this chapter
Cite this chapter
Moliner, A.M. (2010). Creating a European Union Framework for Actions in the Field of Rare Diseases. In: Posada de la Paz, M., Groft, S. (eds) Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology, vol 686. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9485-8_25
Download citation
DOI: https://doi.org/10.1007/978-90-481-9485-8_25
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9484-1
Online ISBN: 978-90-481-9485-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)